

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.01380695 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.83945904 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.60473800 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.60473800 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23917230 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.23917230 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 7.03522932 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.51701089 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.51701089 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.51701089 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.19941506 |
| 12 | tryptophan metabolic process (GO:0006568) | 6.15441654 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.05700878 |
| 14 | oxidative demethylation (GO:0070989) | 6.03818145 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.89901255 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.81507032 |
| 17 | drug metabolic process (GO:0017144) | 5.69980029 |
| 18 | urea cycle (GO:0000050) | 5.56314655 |
| 19 | urea metabolic process (GO:0019627) | 5.56314655 |
| 20 | cysteine metabolic process (GO:0006534) | 5.42706864 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.40105053 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.33094763 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.32404347 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.26819471 |
| 25 | protein carboxylation (GO:0018214) | 5.21609859 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.21609859 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.20961579 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.15795317 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.14170046 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 5.12691158 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.11918869 |
| 32 | regulation of protein activation cascade (GO:2000257) | 5.10899164 |
| 33 | bile acid metabolic process (GO:0008206) | 5.08425502 |
| 34 | phenylpropanoid metabolic process (GO:0009698) | 4.96343122 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.96287727 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92776007 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.88389448 |
| 38 | S-adenosylmethionine metabolic process (GO:0046500) | 4.86770792 |
| 39 | regulation of complement activation (GO:0030449) | 4.76048304 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.71206986 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.70331050 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.69811301 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.69176495 |
| 44 | indolalkylamine metabolic process (GO:0006586) | 4.69001967 |
| 45 | lysine catabolic process (GO:0006554) | 4.67520461 |
| 46 | lysine metabolic process (GO:0006553) | 4.67520461 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61731843 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.61731843 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.61731843 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.58987285 |
| 51 | cellular biogenic amine catabolic process (GO:0042402) | 4.58482475 |
| 52 | amine catabolic process (GO:0009310) | 4.58482475 |
| 53 | ethanol metabolic process (GO:0006067) | 4.56332027 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.54954477 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.54954477 |
| 56 | phospholipid efflux (GO:0033700) | 4.44130354 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.41603992 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.41102335 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.41102335 |
| 60 | cellular glucuronidation (GO:0052695) | 4.40206555 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.39163137 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.39136003 |
| 63 | alkaloid metabolic process (GO:0009820) | 4.37660033 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 4.32271756 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.31860047 |
| 66 | glycine metabolic process (GO:0006544) | 4.25123337 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 4.23885969 |
| 68 | glutamate metabolic process (GO:0006536) | 4.20976924 |
| 69 | drug catabolic process (GO:0042737) | 4.19868271 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 4.17060327 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 4.15112199 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 4.12045983 |
| 73 | cholesterol efflux (GO:0033344) | 4.10163796 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02504787 |
| 75 | aldehyde catabolic process (GO:0046185) | 4.00004106 |
| 76 | ethanol oxidation (GO:0006069) | 3.99747887 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96139817 |
| 78 | glucuronate metabolic process (GO:0019585) | 3.95166436 |
| 79 | uronic acid metabolic process (GO:0006063) | 3.95166436 |
| 80 | arginine metabolic process (GO:0006525) | 3.94842685 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 3.93004154 |
| 82 | regulation of plasminogen activation (GO:0010755) | 3.91355155 |
| 83 | fibrinolysis (GO:0042730) | 3.86531434 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.83718027 |
| 85 | short-chain fatty acid metabolic process (GO:0046459) | 3.81426924 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.81279199 |
| 87 | organic acid catabolic process (GO:0016054) | 3.79768852 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 3.79768852 |
| 89 | ketone body metabolic process (GO:1902224) | 3.79416603 |
| 90 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77598023 |
| 91 | negative regulation of blood coagulation (GO:0030195) | 3.77403220 |
| 92 | negative regulation of hemostasis (GO:1900047) | 3.77403220 |
| 93 | NAD biosynthetic process (GO:0009435) | 3.76682928 |
| 94 | cofactor catabolic process (GO:0051187) | 3.73016417 |
| 95 | drug transmembrane transport (GO:0006855) | 3.73002132 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.71907349 |
| 97 | urate metabolic process (GO:0046415) | 3.68522431 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.67890547 |
| 99 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67691510 |
| 100 | exogenous drug catabolic process (GO:0042738) | 3.66838397 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 3.66568512 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65517004 |
| 103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65517004 |
| 104 | opsonization (GO:0008228) | 3.64881578 |
| 105 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.64425040 |
| 106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.64425040 |
| 107 | arginine catabolic process (GO:0006527) | 3.64165509 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.63948273 |
| 109 | regulation of humoral immune response (GO:0002920) | 3.62262623 |
| 110 | cytolysis (GO:0019835) | 3.61709914 |
| 111 | complement activation, classical pathway (GO:0006958) | 3.61480799 |
| 112 | protein activation cascade (GO:0072376) | 3.61086749 |
| 113 | complement activation (GO:0006956) | 3.58597518 |
| 114 | sterol homeostasis (GO:0055092) | 3.58321237 |
| 115 | flavonoid metabolic process (GO:0009812) | 3.56185437 |
| 116 | heme transport (GO:0015886) | 3.50133453 |
| 117 | negative regulation of protein activation cascade (GO:2000258) | 3.45106145 |
| 118 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.44315598 |
| 119 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.44315598 |
| 120 | acute-phase response (GO:0006953) | 3.42648009 |
| 121 | negative regulation of coagulation (GO:0050819) | 3.42090987 |
| 122 | sodium-independent organic anion transport (GO:0043252) | 3.37451139 |
| 123 | negative regulation of wound healing (GO:0061045) | 3.33442404 |
| 124 | intestinal cholesterol absorption (GO:0030299) | 3.30778071 |
| 125 | xenobiotic metabolic process (GO:0006805) | 3.27965186 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.27142978 |
| 127 | L-methionine salvage (GO:0071267) | 3.25523589 |
| 128 | L-methionine biosynthetic process (GO:0071265) | 3.25523589 |
| 129 | amino acid salvage (GO:0043102) | 3.25523589 |
| 130 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.22800504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.18271191 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.10729733 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.95422021 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.38589713 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21831223 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.99786316 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.26934617 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05803557 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97635481 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.85948260 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.35508359 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.12989156 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10581592 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02667800 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5174778 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.98090568 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91857873 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.90865006 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.88204405 |
| 20 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87432319 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70888125 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.64922536 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64387979 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.62864308 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62002645 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61996490 |
| 27 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58713013 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52526376 |
| 29 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.49915116 |
| 30 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.49915116 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49229596 |
| 32 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.45894530 |
| 33 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.44757367 |
| 34 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40754746 |
| 35 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36735687 |
| 36 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.35144033 |
| 37 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33937075 |
| 38 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33937075 |
| 39 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.30846505 |
| 40 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.30846505 |
| 41 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28639813 |
| 42 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.27565003 |
| 43 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26369342 |
| 44 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25946779 |
| 45 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25581332 |
| 46 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.25020606 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24290406 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22288816 |
| 49 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.21721636 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21715919 |
| 51 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21508039 |
| 52 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.20443105 |
| 53 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19690560 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16511074 |
| 55 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16274022 |
| 56 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15861098 |
| 57 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14497967 |
| 58 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13893035 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12159141 |
| 60 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11689126 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11322120 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10713699 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10713699 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10147386 |
| 65 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08756243 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05954523 |
| 67 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.05949288 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05843043 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04215016 |
| 70 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03604526 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02753107 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02276766 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01375847 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00924235 |
| 75 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00808565 |
| 76 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99963905 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98648978 |
| 78 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98312243 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.98262337 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94863513 |
| 81 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94375043 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94279612 |
| 83 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.93571489 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93005531 |
| 85 | NFYA_21822215_ChIP-Seq_K562_Human | 0.92796020 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92702488 |
| 87 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92116182 |
| 88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88726160 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88352295 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85978790 |
| 91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85631190 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84983513 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81442845 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80094157 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78943092 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73975680 |
| 97 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73726180 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72786311 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72786311 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.71086283 |
| 101 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67105226 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.66985415 |
| 103 | AR_20517297_ChIP-Seq_VCAP_Human | 0.65602903 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64786753 |
| 105 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.64473571 |
| 106 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.64222498 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63307054 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62665523 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62371893 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62364280 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.60995390 |
| 112 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60440817 |
| 113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.59883338 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59621978 |
| 115 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.58327859 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.58079359 |
| 117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.58038131 |
| 118 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.57932805 |
| 119 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57770485 |
| 120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.57399669 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56868188 |
| 122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56386801 |
| 123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56207455 |
| 124 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56155424 |
| 125 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55953957 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55088810 |
| 127 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.54721696 |
| 128 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.54446159 |
| 129 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.53592665 |
| 130 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53538254 |
| 131 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.52140581 |
| 132 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.51084636 |
| 133 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.50872286 |
| 134 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.50728389 |
| 135 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.50365586 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50336289 |
| 137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50257863 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.50144222 |
| 139 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49756656 |
| 140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.49318841 |
| 141 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48165015 |
| 142 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.47885999 |
| 143 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.47659676 |
| 144 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47332667 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.46701460 |
| 146 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43747842 |
| 147 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.43455976 |
| 148 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.42883534 |
| 149 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40936554 |
| 150 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.39387254 |
| 151 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.39258649 |
| 152 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39035935 |
| 153 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.38642458 |
| 154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38581518 |
| 155 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38310966 |
| 156 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37927206 |
| 157 | NCOR_22424771_ChIP-Seq_293T_Human | 0.37919542 |
| 158 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.37748971 |
| 159 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.37545121 |
| 160 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36354309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.27574082 |
| 2 | MP0005360_urolithiasis | 7.64383211 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.42056692 |
| 4 | MP0005365_abnormal_bile_salt | 6.15395799 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15240717 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08796700 |
| 7 | MP0003252_abnormal_bile_duct | 3.98538247 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.46217962 |
| 9 | MP0003195_calcinosis | 3.15716649 |
| 10 | MP0009840_abnormal_foam_cell | 2.95154885 |
| 11 | MP0005083_abnormal_biliary_tract | 2.92408330 |
| 12 | MP0005332_abnormal_amino_acid | 2.87780217 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.55738573 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.37867955 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.19800797 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.14795931 |
| 17 | MP0000609_abnormal_liver_physiology | 2.08342000 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.06034176 |
| 19 | MP0003868_abnormal_feces_composition | 1.91425885 |
| 20 | MP0001764_abnormal_homeostasis | 1.78308833 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.78284375 |
| 22 | MP0009697_abnormal_copulation | 1.77860930 |
| 23 | MP0005451_abnormal_body_composition | 1.59111429 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53855230 |
| 25 | MP0008877_abnormal_DNA_methylation | 1.39176195 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.38672130 |
| 27 | MP0003646_muscle_fatigue | 1.36781269 |
| 28 | MP0003011_delayed_dark_adaptation | 1.35520324 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.31221946 |
| 30 | MP0003186_abnormal_redox_activity | 1.28540115 |
| 31 | MP0005647_abnormal_sex_gland | 1.20901105 |
| 32 | MP0009764_decreased_sensitivity_to | 1.16201825 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.13736056 |
| 34 | MP0004142_abnormal_muscle_tone | 1.13102404 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.12684951 |
| 36 | MP0000598_abnormal_liver_morphology | 1.11904032 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 1.07179105 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.05958129 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.05847530 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.01020424 |
| 41 | MP0009763_increased_sensitivity_to | 0.97813918 |
| 42 | MP0005379_endocrine/exocrine_gland_phen | 0.95847880 |
| 43 | MP0001501_abnormal_sleep_pattern | 0.95678923 |
| 44 | MP0009745_abnormal_behavioral_response | 0.95416920 |
| 45 | MP0002254_reproductive_system_inflammat | 0.95320324 |
| 46 | MP0005408_hypopigmentation | 0.92833128 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.91004398 |
| 48 | MP0008469_abnormal_protein_level | 0.89757191 |
| 49 | MP0009642_abnormal_blood_homeostasis | 0.89589826 |
| 50 | MP0000604_amyloidosis | 0.88884589 |
| 51 | MP0006292_abnormal_olfactory_placode | 0.88172833 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 0.87775543 |
| 53 | MP0009785_altered_susceptibility_to | 0.87475238 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 0.86655139 |
| 55 | MP0005670_abnormal_white_adipose | 0.85297523 |
| 56 | MP0010368_abnormal_lymphatic_system | 0.84878930 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.82472027 |
| 58 | MP0002282_abnormal_trachea_morphology | 0.80334495 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 0.78676213 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.78483042 |
| 61 | MP0005376_homeostasis/metabolism_phenot | 0.77659328 |
| 62 | MP0005535_abnormal_body_temperature | 0.77152394 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 0.76000523 |
| 64 | MP0001756_abnormal_urination | 0.73196518 |
| 65 | MP0005334_abnormal_fat_pad | 0.71153841 |
| 66 | MP0001968_abnormal_touch/_nociception | 0.70376692 |
| 67 | MP0009046_muscle_twitch | 0.70245817 |
| 68 | MP0001661_extended_life_span | 0.69709440 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 0.68361529 |
| 70 | MP0003879_abnormal_hair_cell | 0.67053363 |
| 71 | MP0001984_abnormal_olfaction | 0.67045002 |
| 72 | MP0002971_abnormal_brown_adipose | 0.65908480 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.64414860 |
| 74 | MP0000569_abnormal_digit_pigmentation | 0.64311765 |
| 75 | MP0002102_abnormal_ear_morphology | 0.64061061 |
| 76 | MP0004133_heterotaxia | 0.63007262 |
| 77 | MP0005253_abnormal_eye_physiology | 0.62815522 |
| 78 | MP0005386_behavior/neurological_phenoty | 0.62734101 |
| 79 | MP0004924_abnormal_behavior | 0.62734101 |
| 80 | MP0002928_abnormal_bile_duct | 0.62521500 |
| 81 | MP0002909_abnormal_adrenal_gland | 0.61418231 |
| 82 | MP0005377_hearing/vestibular/ear_phenot | 0.61159308 |
| 83 | MP0003878_abnormal_ear_physiology | 0.61159308 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.60722722 |
| 85 | MP0005266_abnormal_metabolism | 0.58788717 |
| 86 | MP0002272_abnormal_nervous_system | 0.58717028 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.58622118 |
| 88 | MP0003690_abnormal_glial_cell | 0.58615242 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.58536742 |
| 90 | MP0005410_abnormal_fertilization | 0.58268685 |
| 91 | MP0002064_seizures | 0.58256426 |
| 92 | MP0005187_abnormal_penis_morphology | 0.57040540 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.56567262 |
| 94 | MP0004043_abnormal_pH_regulation | 0.54371778 |
| 95 | MP0009053_abnormal_anal_canal | 0.53391045 |
| 96 | MP0005448_abnormal_energy_balance | 0.53012804 |
| 97 | MP0005395_other_phenotype | 0.52604349 |
| 98 | MP0004130_abnormal_muscle_cell | 0.52035872 |
| 99 | MP0004381_abnormal_hair_follicle | 0.51273990 |
| 100 | MP0003724_increased_susceptibility_to | 0.50381203 |
| 101 | MP0001486_abnormal_startle_reflex | 0.48801729 |
| 102 | MP0005464_abnormal_platelet_physiology | 0.48788333 |
| 103 | MP0004147_increased_porphyrin_level | 0.48504926 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.48277276 |
| 105 | MP0002653_abnormal_ependyma_morphology | 0.48037761 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.47675773 |
| 107 | MP0003633_abnormal_nervous_system | 0.47567068 |
| 108 | MP0003953_abnormal_hormone_level | 0.47220999 |
| 109 | MP0003718_maternal_effect | 0.46946882 |
| 110 | MP0000427_abnormal_hair_cycle | 0.46479772 |
| 111 | MP0004742_abnormal_vestibular_system | 0.45923186 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.44305485 |
| 113 | MP0003638_abnormal_response/metabolism_ | 0.43925694 |
| 114 | MP0000579_abnormal_nail_morphology | 0.43830622 |
| 115 | MP0008874_decreased_physiological_sensi | 0.41851614 |
| 116 | MP0003329_amyloid_beta_deposits | 0.41760410 |
| 117 | MP0002822_catalepsy | 0.40275507 |
| 118 | MP0003436_decreased_susceptibility_to | 0.39851571 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.39542645 |
| 120 | MP0002168_other_aberrant_phenotype | 0.38593665 |
| 121 | MP0008873_increased_physiological_sensi | 0.36448273 |
| 122 | MP0002132_abnormal_respiratory_system | 0.35731297 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.35693252 |
| 124 | MP0009672_abnormal_birth_weight | 0.35255143 |
| 125 | MP0008872_abnormal_physiological_respon | 0.35212446 |
| 126 | MP0001944_abnormal_pancreas_morphology | 0.31918436 |
| 127 | MP0005166_decreased_susceptibility_to | 0.31492275 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.30646307 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.30393965 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.29536490 |
| 131 | MP0009115_abnormal_fat_cell | 0.29493103 |
| 132 | MP0003075_altered_response_to | 0.29368536 |
| 133 | MP0001853_heart_inflammation | 0.29250503 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.29006657 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.28457126 |
| 136 | MP0000249_abnormal_blood_vessel | 0.28131528 |
| 137 | MP0006082_CNS_inflammation | 0.27086219 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.25430377 |
| 139 | MP0004264_abnormal_extraembryonic_tissu | 0.25186669 |
| 140 | MP0004883_abnormal_blood_vessel | 0.25119408 |
| 141 | MP0001881_abnormal_mammary_gland | 0.24684132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42705470 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.27692575 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.02841325 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.58958541 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.55618947 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.13947823 |
| 7 | Xanthomatosis (HP:0000991) | 6.06674451 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.32211748 |
| 9 | Complement deficiency (HP:0004431) | 5.11303974 |
| 10 | Joint hemorrhage (HP:0005261) | 4.95802493 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.55828524 |
| 12 | Hyperammonemia (HP:0001987) | 4.52154807 |
| 13 | Epidermoid cyst (HP:0200040) | 4.50762756 |
| 14 | Hyperglycinemia (HP:0002154) | 4.49951877 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.40522839 |
| 16 | Ketosis (HP:0001946) | 4.36351585 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.35955205 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.30845262 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30844477 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.28309138 |
| 21 | Hyperglycinuria (HP:0003108) | 4.19400319 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.17508186 |
| 23 | Fat malabsorption (HP:0002630) | 4.15415225 |
| 24 | Conjugated hyperbilirubinemia (HP:0002908) | 4.09415750 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.05790692 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.05790692 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.01841247 |
| 28 | Hypoglycemic coma (HP:0001325) | 4.01450169 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.96531248 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77378519 |
| 31 | Abnormality of complement system (HP:0005339) | 3.68966716 |
| 32 | Fair hair (HP:0002286) | 3.57039732 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.51395078 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40622739 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.36474645 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32253905 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.29274266 |
| 38 | Ketoacidosis (HP:0001993) | 3.26708713 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.14249772 |
| 40 | Steatorrhea (HP:0002570) | 3.11518344 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.96522954 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 2.94868472 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.92990776 |
| 44 | Metabolic acidosis (HP:0001942) | 2.90448733 |
| 45 | Myocardial infarction (HP:0001658) | 2.87627492 |
| 46 | Spontaneous abortion (HP:0005268) | 2.85937055 |
| 47 | Hypoglycemic seizures (HP:0002173) | 2.84703046 |
| 48 | Nephritis (HP:0000123) | 2.81219176 |
| 49 | Vascular calcification (HP:0004934) | 2.77472810 |
| 50 | Gout (HP:0001997) | 2.72292223 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.72284828 |
| 52 | Bile duct proliferation (HP:0001408) | 2.69312733 |
| 53 | Abnormal biliary tract physiology (HP:0012439) | 2.69312733 |
| 54 | Generalized hypopigmentation of hair (HP:0011358) | 2.66977018 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66802847 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.66802847 |
| 57 | Skin nodule (HP:0200036) | 2.65164099 |
| 58 | Lethargy (HP:0001254) | 2.64722115 |
| 59 | Pancreatic cysts (HP:0001737) | 2.52183245 |
| 60 | Enlarged kidneys (HP:0000105) | 2.50645697 |
| 61 | Glomerulonephritis (HP:0000099) | 2.43777126 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.42932938 |
| 63 | Acanthocytosis (HP:0001927) | 2.42242631 |
| 64 | Cerebral edema (HP:0002181) | 2.42055718 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.41765734 |
| 66 | Renal cortical cysts (HP:0000803) | 2.40066218 |
| 67 | Mitral stenosis (HP:0001718) | 2.38976218 |
| 68 | Irritability (HP:0000737) | 2.37446323 |
| 69 | Congenital stationary night blindness (HP:0007642) | 2.36231195 |
| 70 | Abnormality of the renal cortex (HP:0011035) | 2.32284549 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31561448 |
| 72 | Hyperventilation (HP:0002883) | 2.31483788 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 2.29902206 |
| 74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27532334 |
| 75 | Arthropathy (HP:0003040) | 2.25594342 |
| 76 | Neonatal onset (HP:0003623) | 2.24902250 |
| 77 | Spastic diplegia (HP:0001264) | 2.24487515 |
| 78 | Malnutrition (HP:0004395) | 2.23995971 |
| 79 | Pancreatitis (HP:0001733) | 2.23522205 |
| 80 | * Delayed CNS myelination (HP:0002188) | 2.22220620 |
| 81 | Alkalosis (HP:0001948) | 2.22181218 |
| 82 | Abnormality of vitamin metabolism (HP:0100508) | 2.20704456 |
| 83 | Late onset (HP:0003584) | 2.20395937 |
| 84 | Menorrhagia (HP:0000132) | 2.19481906 |
| 85 | Gingival bleeding (HP:0000225) | 2.19247005 |
| 86 | Cholelithiasis (HP:0001081) | 2.17915681 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16925938 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 2.16925938 |
| 89 | Hyperalaninemia (HP:0003348) | 2.16925938 |
| 90 | Chronic hepatic failure (HP:0100626) | 2.16191758 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 2.15367774 |
| 92 | Brushfield spots (HP:0001088) | 2.15240337 |
| 93 | Rickets (HP:0002748) | 2.15146701 |
| 94 | Vomiting (HP:0002013) | 2.12378674 |
| 95 | Pancreatic fibrosis (HP:0100732) | 2.12220648 |
| 96 | Opisthotonus (HP:0002179) | 2.11166771 |
| 97 | Osteomalacia (HP:0002749) | 2.09904635 |
| 98 | Amyloidosis (HP:0011034) | 2.09312437 |
| 99 | Esophageal varix (HP:0002040) | 2.09037566 |
| 100 | Hydroxyprolinuria (HP:0003080) | 2.08750017 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.08750017 |
| 102 | Type II lissencephaly (HP:0007260) | 2.08661551 |
| 103 | Proximal tubulopathy (HP:0000114) | 2.08281899 |
| 104 | Hypophosphatemic rickets (HP:0004912) | 2.08268863 |
| 105 | Hypothermia (HP:0002045) | 2.07252307 |
| 106 | True hermaphroditism (HP:0010459) | 2.05845487 |
| 107 | Abnormality of midbrain morphology (HP:0002418) | 2.05012265 |
| 108 | Molar tooth sign on MRI (HP:0002419) | 2.05012265 |
| 109 | Symptomatic seizures (HP:0011145) | 2.03524988 |
| 110 | Thrombophlebitis (HP:0004418) | 2.01172860 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99486319 |
| 112 | Cholecystitis (HP:0001082) | 1.98927939 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 1.98927939 |
| 114 | Glycosuria (HP:0003076) | 1.96089620 |
| 115 | Abnormality of urine glucose concentration (HP:0011016) | 1.96089620 |
| 116 | Increased purine levels (HP:0004368) | 1.93337684 |
| 117 | Hyperuricemia (HP:0002149) | 1.93337684 |
| 118 | Poikilocytosis (HP:0004447) | 1.93193640 |
| 119 | Hemorrhage of the eye (HP:0011885) | 1.88751834 |
| 120 | Elevated hepatic transaminases (HP:0002910) | 1.88704206 |
| 121 | Abnormality of the gallbladder (HP:0005264) | 1.88068577 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86836419 |
| 123 | Azoospermia (HP:0000027) | 1.85532970 |
| 124 | Pulmonary embolism (HP:0002204) | 1.85452849 |
| 125 | Hyperglycemia (HP:0003074) | 1.83518384 |
| 126 | Nephronophthisis (HP:0000090) | 1.83387240 |
| 127 | Hyperphosphaturia (HP:0003109) | 1.80248345 |
| 128 | Neonatal hypoglycemia (HP:0001998) | 1.78411667 |
| 129 | Methylmalonic acidemia (HP:0002912) | 1.77099953 |
| 130 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75938250 |
| 131 | Decreased central vision (HP:0007663) | 1.75754619 |
| 132 | 3-Methylglutaconic aciduria (HP:0003535) | 1.74631262 |
| 133 | Hypochromic anemia (HP:0001931) | 1.73701764 |
| 134 | Attenuation of retinal blood vessels (HP:0007843) | 1.72699065 |
| 135 | Gangrene (HP:0100758) | 1.72323664 |
| 136 | Blue irides (HP:0000635) | 1.72060731 |
| 137 | Tubular atrophy (HP:0000092) | 1.70576293 |
| 138 | Retrobulbar optic neuritis (HP:0100654) | 1.70308848 |
| 139 | Optic neuritis (HP:0100653) | 1.70308848 |
| 140 | Abnormal drinking behavior (HP:0030082) | 1.64403349 |
| 141 | Polydipsia (HP:0001959) | 1.64403349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.67224637 |
| 2 | FGFR4 | 4.32799967 |
| 3 | INSRR | 4.17952295 |
| 4 | SIK1 | 4.03768120 |
| 5 | TAOK3 | 3.63773815 |
| 6 | ERN1 | 3.60577070 |
| 7 | MAP4K2 | 2.79873288 |
| 8 | ERBB4 | 2.76331471 |
| 9 | ZAK | 2.50692763 |
| 10 | BMPR1B | 2.30922576 |
| 11 | TLK1 | 2.25451094 |
| 12 | MST1R | 2.10803052 |
| 13 | PIK3CG | 2.09237990 |
| 14 | ACVR1B | 2.08888652 |
| 15 | MAP2K4 | 1.98973133 |
| 16 | FLT3 | 1.95063714 |
| 17 | MAPK13 | 1.94365328 |
| 18 | LATS1 | 1.90955626 |
| 19 | MAPK11 | 1.79565317 |
| 20 | FRK | 1.78347312 |
| 21 | MAP3K4 | 1.72205106 |
| 22 | MAP3K14 | 1.70376726 |
| 23 | TYK2 | 1.70327753 |
| 24 | IRAK3 | 1.60519502 |
| 25 | STK38L | 1.59644538 |
| 26 | PINK1 | 1.56658184 |
| 27 | TXK | 1.52475824 |
| 28 | STK39 | 1.49185726 |
| 29 | CASK | 1.46742784 |
| 30 | NTRK3 | 1.32332667 |
| 31 | MAPK15 | 1.28396360 |
| 32 | NEK9 | 1.27135316 |
| 33 | PRKAA2 | 1.23188056 |
| 34 | ABL2 | 1.22795417 |
| 35 | TNK2 | 1.21954978 |
| 36 | CAMKK2 | 1.21737476 |
| 37 | DAPK2 | 1.17205458 |
| 38 | PTK6 | 1.14634884 |
| 39 | FGFR2 | 1.12985897 |
| 40 | JAK2 | 1.11536814 |
| 41 | PKN2 | 1.10960018 |
| 42 | JAK1 | 1.09121893 |
| 43 | MAP3K7 | 1.08195081 |
| 44 | MAPKAPK3 | 1.06280798 |
| 45 | ITK | 1.02475818 |
| 46 | EPHA3 | 0.99843538 |
| 47 | TIE1 | 0.96694738 |
| 48 | TBK1 | 0.96561830 |
| 49 | PTK2B | 0.96448450 |
| 50 | PAK3 | 0.96331183 |
| 51 | PNCK | 0.95616373 |
| 52 | SGK2 | 0.94596013 |
| 53 | PRKCE | 0.93461358 |
| 54 | ERBB2 | 0.91912014 |
| 55 | CAMK1D | 0.91430273 |
| 56 | GRK1 | 0.91055681 |
| 57 | MAPK4 | 0.89070058 |
| 58 | KDR | 0.89030944 |
| 59 | SGK3 | 0.88603383 |
| 60 | ADRBK1 | 0.87653400 |
| 61 | WNK3 | 0.86071096 |
| 62 | PRKCZ | 0.85252182 |
| 63 | IKBKE | 0.82990978 |
| 64 | MAP2K6 | 0.80169491 |
| 65 | MAP2K3 | 0.79944317 |
| 66 | TAOK2 | 0.76738131 |
| 67 | MAP2K7 | 0.76640787 |
| 68 | MAP3K3 | 0.74446404 |
| 69 | GRK6 | 0.74265958 |
| 70 | PRKAA1 | 0.74063116 |
| 71 | BRSK2 | 0.72604760 |
| 72 | PRKACG | 0.71817764 |
| 73 | IRAK2 | 0.71666322 |
| 74 | DYRK2 | 0.70077428 |
| 75 | SGK223 | 0.69957682 |
| 76 | SGK494 | 0.69957682 |
| 77 | MET | 0.69509120 |
| 78 | CSK | 0.68576982 |
| 79 | GSK3A | 0.68054363 |
| 80 | NUAK1 | 0.67823398 |
| 81 | AKT3 | 0.66807424 |
| 82 | MAPK12 | 0.65008416 |
| 83 | DYRK1B | 0.63745824 |
| 84 | CDK6 | 0.63145266 |
| 85 | IRAK1 | 0.63078586 |
| 86 | MAPK7 | 0.62931371 |
| 87 | SIK2 | 0.62852705 |
| 88 | CAMK2G | 0.62789505 |
| 89 | GRK7 | 0.62100116 |
| 90 | EPHB1 | 0.62007065 |
| 91 | PRKCQ | 0.60198328 |
| 92 | WNK4 | 0.59821078 |
| 93 | PHKG1 | 0.59443337 |
| 94 | PHKG2 | 0.59443337 |
| 95 | FGFR3 | 0.58488949 |
| 96 | KIT | 0.56973273 |
| 97 | FER | 0.56480864 |
| 98 | PRKG1 | 0.55841030 |
| 99 | TEC | 0.55393497 |
| 100 | PTK2 | 0.52443406 |
| 101 | MUSK | 0.52270890 |
| 102 | SYK | 0.52176868 |
| 103 | TRPM7 | 0.51492150 |
| 104 | TNIK | 0.51220936 |
| 105 | PKN1 | 0.50846044 |
| 106 | MARK1 | 0.49595487 |
| 107 | CSNK1A1 | 0.49390768 |
| 108 | MKNK2 | 0.48348602 |
| 109 | IGF1R | 0.47206817 |
| 110 | CAMK1G | 0.45888809 |
| 111 | CSNK1D | 0.45336816 |
| 112 | STK11 | 0.45030041 |
| 113 | CSF1R | 0.44472934 |
| 114 | MAP3K13 | 0.44346489 |
| 115 | TRIB3 | 0.44252700 |
| 116 | PDPK1 | 0.44210067 |
| 117 | ERBB3 | 0.43419957 |
| 118 | TGFBR2 | 0.42592231 |
| 119 | BCR | 0.41102799 |
| 120 | MAP3K5 | 0.39548927 |
| 121 | CSNK1G1 | 0.39107241 |
| 122 | PRKCG | 0.38865526 |
| 123 | MARK3 | 0.38686053 |
| 124 | CAMK2A | 0.38288805 |
| 125 | CHUK | 0.38241629 |
| 126 | LYN | 0.38231536 |
| 127 | VRK1 | 0.38049972 |
| 128 | MATK | 0.37795374 |
| 129 | RPS6KA5 | 0.37384211 |
| 130 | CAMK4 | 0.36338768 |
| 131 | PRKACB | 0.35060485 |
| 132 | STK16 | 0.34864598 |
| 133 | CSNK1G2 | 0.34725400 |
| 134 | NLK | 0.34619729 |
| 135 | PDK2 | 0.33433178 |
| 136 | MAP3K11 | 0.31358713 |
| 137 | MAPKAPK5 | 0.30852583 |
| 138 | PRKCA | 0.30623099 |
| 139 | EIF2AK2 | 0.28995535 |
| 140 | IRAK4 | 0.27667512 |
| 141 | MAP3K10 | 0.27364329 |
| 142 | MAP3K1 | 0.26812694 |
| 143 | ADRBK2 | 0.26209328 |
| 144 | JAK3 | 0.25956112 |
| 145 | PIK3CA | 0.24846891 |
| 146 | MAPK3 | 0.23568616 |
| 147 | PDK1 | 0.23521998 |
| 148 | PRKACA | 0.23072583 |
| 149 | IKBKB | 0.22286705 |
| 150 | RPS6KB1 | 0.22105505 |
| 151 | ABL1 | 0.21608636 |
| 152 | OXSR1 | 0.21102374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44516543 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40913310 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38229845 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25596492 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95624585 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.81519650 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.68191886 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62830518 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57899015 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51393068 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49000003 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46384113 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39879223 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22814221 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.18376021 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18016912 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.03301889 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97796184 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96392523 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95520893 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94242655 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81980390 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79196864 |
| 24 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77870521 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72232069 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70998506 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68391664 |
| 28 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64027551 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63976246 |
| 30 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63035761 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62696084 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61191796 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51977964 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49206300 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.48695614 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47028413 |
| 37 | * Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43903731 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40539648 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35219398 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34033593 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32499066 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.32201427 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.27968913 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25274781 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22763172 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22678544 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18077779 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09326696 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07695889 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04292023 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03431841 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00633783 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00072212 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00055995 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95280127 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94386429 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91127029 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.87080788 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86539286 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77285810 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66439803 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66185990 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62710790 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53729593 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.51212708 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49966112 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48749131 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47813307 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40953890 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39822053 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38093968 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35428427 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30593820 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.28522067 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28108699 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25312186 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.24968678 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.24631998 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23732573 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.20997171 |
| 81 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17576090 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17331289 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16910852 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15538618 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14018041 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.14006547 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.13190832 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.12889531 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.11604200 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09957472 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07450064 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.06507146 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.03467546 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.01786618 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.01218019 |
| 96 | Lysosome_Homo sapiens_hsa04142 | -0.2420742 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | -0.2418413 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2303506 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2171459 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2081335 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2078532 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1961945 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1842405 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1809296 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1788745 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1561456 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | -0.1559847 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1456916 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1434120 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0803193 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0762566 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0641269 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0570031 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0313099 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0277626 |
| 116 | Homologous recombination_Homo sapiens_hsa03440 | -0.0202584 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0179044 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0136208 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0061964 |
| 120 | Basal transcription factors_Homo sapiens_hsa03022 | -0.0048049 |

